1. .
2. TOF - , .
3. (TOF 90%) :
a. - TOF 0 . .
b. TOF 1-3 .
c. - TOF 1-89%.
4. (TOF 90%).
5. , .
6. :
a. 4 / - TOF 0-1 , TOF-, ;
b. 2 / - TOF 2 ;
c. 16 / - ( ).
7. TOF 90% .
8. 24 . , .
9. .
10. , , .
1. Beecher H.K., Todd D.P. A study of the deaths associated with anesthesia and surgery: based on a study of 599, 548 anesthesias in ten institutions 19481952, inclusive. // Ann Surg 1954;140:235
2. Viby-Mogensen J., Jorgensen B.C., Ording H. Residual curarization in the recovery room. // Anesthesiology 1979;50:53941
3. Beemer G.H., Rozental P. Postoperative neuromuscular function. // Anaesth Intensive Care 1986;14:415;
4. Cammu G., De Witte J., De Veylder J. et al. Postoperative residual paralysis in outpatients versus inpatients // Anesth Analg 2006;102:4269
|
|
|
5. Lowson S.M., Sawh S. Adjuncts to analgesia: sedation and neuromuscular blockade. // Crit Care Clin. 1999;15:119-141
6. Murphy G.S., Szokol J.W., Marymont J.H. et al. Residual neuromuscular blockade and critical respiratory events in the postanesthesia care unit. Anesth Analg. 2008;107(1):130-7.
7. Berg H., Viby Mogensen J., Roed J. et al. Residual neuromuscular block is a risk factor for postoperative pulmonary complicatons A prospective, randomized, and blinded study of postoperative pulmonary complications after atracurium, vecuronium and pancuronium.//Acta Anaesthesiol. Scand 1997; 41: 1095103
8. .. . V . -. -. -1999. . 267-268
9. .., .., .. . - // IX - . . - 2011. - .83
10. Carman J. A. History of curare // Anaesthesia 1968;23(4):706-7
11. Paton DF. Posterior dislocation of the shoulder. A diagnostic pitfall for physicians. Practitioner. 1979;223(1333):111112
12. Dale H. H. J. The action certain esters and ethers of cholin, and their relation to muscarine // Pharmac. Exp. Ther. 1914, 6, 147-190
13. Dale H. H. Chemical transmission of the effects of nerve impulses // Br. Med. J. 1934, 12; 1(3827): 835841
14. King H. Curare alkaloids. I. Tubocurarine J. Chem. Soc. 1935, 13819
15. Griffith H., Johnson G.E. The use of curare in general anesthesia //Anesthesiology, 1942. - P.418-420
16. Society of Critical Care Medicine and American Society of Health-System Pharmacists. Clinical practice guidelines for sustained neuromuscular blockade in the adult critically ill patient. // Am J Health Syst Pharm. 2002; 59:17995
17. Belkin A., Alasheev A.M., Gulin G.A The frequency of the involving of phrenic nerve into the polyneuropathy of critical illness // Journal of Neurological Anesthesiology. - 2004 - Volume 16 - Issue 4 - p 343
18. .., .. . , .1. .2009. .357-360. NCT00893633
19. Donati F. Neuromuscular blocking drugs for the new millennium: current practice, future trendscomparative pharmacology of neuromuscular blocking drugs. // Anesth Analg. 2000;90(5 suppl):S2-S6.
20. Churchill-Davidson H.C., Christie J.H. Diagnosis of neuromuscular block in man. // Br J Anaesth 1959; 31: 290-95
21. Donati F., Antzaka C., Bevan D.R. Potency of pancuronium at the diaphragm and the adductor pollicis muscle in humans. // Anesthesiology 1986;65: 1-5
22. Viby-Mogensen J. Neuromuscular monitoring. // In: Miller RD, ed. Millers Anesthesia. 6th ed. Philadelphia, PA: Churchill Livingstone; 2005:1557-1570;
23. Donati F., Meistelman C., Plaud B. Vecuronium neuromuscular blockade at the diaphragm, the orbicularis oculi, and adductor pollicis muscles. // Anesthesiology 1990; 73: 870-5
24. Plaud B., Debaene B., Donati F. The corrugators supercilii, not the orbicularis oculi, reflects rocuronium neuromuscular blockade at the laryngeal adductor muscles. // Anesthesiology 2001; 95: 96-101
|
|
|
25. Saitoh Y., Fujii Y., Takahashi K. et al. Recovery of post-tetanic count and train of four responses at the great toe and thumb. // Anaesthesia 1998; 53: 244-8).
26. Martin L.D., Bratton S.L., ORoarke P.P. Clinical uses and controversies of neuromuscular blocking agents in infants and children. // Crit Care Med. 1999;27:1358-1368).
27. Iwasaki H., Namiki A., Omote K. et al. Response differences of paretic and healthy extremities to pancuronium and neostigmine in hemiplegic patients. // Anesth Analg 1985;64:864-6.
28. . , . . // , - 2000. 1
29. Suy K., Morias K., Cammu G. et al. Effective reversal of moderate rocuronium- or vecuronium-induced neuromuscular block with sugammadex, a selective relaxant binding agent. // Anesthesiology. 2007;106(2):283-8
30. Duvaldestin P., Kuizenga K., Saldien V. et al. A randomized, dose-response study of sugammadex given for the reversal of deep rocuronium- or vecuronium-induced neuromuscular blockade under sevoflurane anesthesia. // Anesth Analg. 2010;110(1):74-82
31. Schaller S.J., Fink H., Ulm K. et al. Sugammadex and neostigmine dose-finding study for reversal of shallow residual neuromuscular block. // Anesthesiology. 2010;113(5):1054-60
32. Jones R.K., Caldwell J.E., Brull S.J. et al. Reversal of profound rocuronium-induced blockade with sugammadex: a randomized comparison with neostigmine. // Anesthesiology. 2008;109(5):816-24
33. Khuenl-Brady K.S., Wattwil M., Vanacker B.F. et al. Sugammadex provides faster reversal of vecuronium-induced neuromuscular blockade compared with neostigmine: a multicenter, randomized, controlled trial. // Anesth Analg. 2010;110(1):64-73
34. Illman H.L., Laurila P., Antila H. et al. The duration of residual neuromuscular block after administration of neostigmine or sugammadex at two visible twitches during train-of-four monitoring. // Anesth Analg. 2011;112(1):63-8
35. Krylov V., Solodov A., Petrikov S. et al. Residual neuromuscular blockade after rocuronium bromide administration in the neurosurgical patients. Incidence and treatment opportunities. // Intensive Care Medicine. 2011. Vol. 37. Suppl.1. S.252 (Abs 0986)
